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The evolution of human anatomical features likely
involved changes in gene regulation during develop-
ment. However, the nature and extent of human-
specific developmental regulatory functions remain
unknown. We obtained a genome-wide view of cis-
regulatory evolution in human embryonic tissues by
comparing the histone modification H3K27ac, which
provides a quantitative readout of promoter and
enhancer activity, during human, rhesus, and mouse
limb development. Based on increased H3K27ac, we
find that 13% of promoters and 11% of enhancers
have gained activity on the human lineage since the
human-rhesus divergence. These gains largely arose
by modification of ancestral regulatory activities in
the limb or potential co-option from other tissues
and are likely to have heterogeneous genetic causes.
Most enhancers that exhibit gain of activity in hu-
mans originated in mammals. Gains at promoters
and enhancers in the human limb are associated
with increased gene expression, suggesting they
include molecular drivers of human morphological
evolution.
INTRODUCTION
Morphological change is a central feature of human evolution.
Humans exhibit characteristic physical differences, such as
increased brain size and specialization of the limbs, relative to
other primate species. Many of these differences emerge early
in human development; for example, the distinct morphologies
of the human hand and foot are evident by gestational day 54
(Schoenwolf et al., 2009). The genetic drivers of most human-
specific traits remain unknown. It has long been thought that
changes in gene regulation contributed to human-specificmorphological adaptations by altering the level and distribution
of gene expression during development (King and Wilson,
1975;Wray, 2007). Changes in developmental enhancer function
have been shown to underlie evolutionary differences in model
organisms and also contribute to human morphological defects
(Lettice et al., 2003; Wittkopp and Kalay, 2012). However,
changes in the activity of developmental regulatory elements
during human evolution have yet to be characterized on a
genome-wide scale, in large part because comprehensive
maps of promoters and enhancers active in human embryonic
tissues are lacking.
Previous efforts to identify developmental regulatory elements
with human-specific functions have largely relied on indirect
computational approaches. Comparative analyses of conserved
noncoding sequences have identified putative enhancers
showing accelerated rates of sequence change on the human
lineage or that have been lost from the human genome (McLean
et al., 2011; Pollard et al., 2006; Prabhakar et al., 2006). A hand-
ful of these sequences have associated experimental evidence
supporting human-specific gain or loss of enhancer function
during embryonic development (McLean et al., 2011; Prabhakar
et al., 2008). These studies are restricted to regulatory elements
that are highly conserved across species and cannot detect
human-specific regulatory functions arising from a small number
of sequence changes with large effects. They also do not pro-
vide a means to predict tissue-specific changes in regulatory
activity.
Global analyses of transcription factor binding and histone
modifications have been employed to compare cis-regulatory
activity in a variety of human and nonhuman cell lines and adult
tissues (Kunarso et al., 2010; Mikkelsen et al., 2010; Schmidt
et al., 2010). Although these studies illustrate the potential
advantages of a comparative functional genomics strategy for
identifying regulatory changes on the human lineage, they
provide limited insight into development. The experimental
systems used do not recapitulate embryonic tissues, and in
comparisons of cultured cell systems, the cell types utilized
may not represent an unambiguously homologous biologicalCell 154, 185–196, July 3, 2013 ª2013 Elsevier Inc. 185
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Human Limb H3K27ac Figure 1. Genome-wide Identification of
Promoters and Enhancers Active in Human
Embryonic Limb
(A) Annotating reproducible H3K27ac-enriched
regions in limb. Top: union of all H3K27ac regions
identified at one or more time points. Bottom:
annotation at each time point. A schematic of
limb morphology is shown for each stage (not
to scale). See also Figures S1A and S1B and
Table S1.
(B) K-means clustering of H3K27ac signals across
104,228 putative enhancer regions identified in
human limb or ENCODE cell lines (k = 8). The
bracket indicates a cluster of enhancers strongly
marked in limb compared to the other data sets.
See also Figure S1D.
(C) Gene ontology and human phenotype enrich-
ments calculated by GREAT (McLean et al., 2010)
(y axis = log10 binomial p value) for the strong
limb-specific enhancers in (B). See also Fig-
ure S1D.
(D) Percentage of human enhancers annotated in
the VISTA Enhancer Browser as active in limb
or other tissues that are marked by H3K27ac in
human limb (Visel et al., 2007). The p value was
calculated using Fisher’s exact test.state across species (Kunarso et al., 2010; Mikkelsen et al.,
2010). Understanding the nature and rate of human-specific
developmental regulatory change ultimately requires direct
functional comparisons of human and nonhuman embryonic
structures. However, such studies have not been feasible
due to the extremely limited availability of relevant primate
specimens.
We address this issue by using comparative analysis of the
histone modification H3K27ac in human, rhesus macaque,
and mouse embryonic limb at multiple stages of development.
The limb is well suited for this purpose: its homology is unam-
biguous across all three species, its development has been
extensively studied in model systems (Zeller et al., 2009), and
it exhibits human-specific morphology that likely originates
during the stages we examined. The scarcity of human and
rhesus embryonic material required us to target a single, highly
sensitive marker of promoter and enhancer activity. Previous
studies have established that H3K27ac chromatin immunopre-
cipitation (ChIP)-seq profiling identifies active promoters
and enhancers in embryonic and adult tissues and can be
efficiently carried out with small amounts of input material
(Cotney et al., 2012; Rada-Iglesias et al., 2012). Moreover,
the level of H3K27ac marking at promoters and enhancers
correlates with the level of nearby gene expression, so line-
age-specific increases in H3K27ac may identify lineage-
specific increases in regulatory element activity (Cotney et al.,
2012). In this study, we developed and applied a statistical
framework for quantitative phylogenetic comparisons of
histone modification signatures. We find that increases in186 Cell 154, 185–196, July 3, 2013 ª2013 Elsevier Inc.H3K27ac are associated with increases
in gene expression and enhancer activity
in the human limb and reveal thousandsof promoters and enhancers with potential lineage-specific
functions.
RESULTS
MappingActive Promoters andEnhancers in theHuman,
Rhesus, and Mouse Embryonic Limb
To identify promoters and enhancers with a potential gain of ac-
tivity on the human lineage since the human-rhesus divergence,
hereafter referred to as ‘‘human lineage gains,’’ we performed
ChIP-seq of H3K27ac in human, rhesus, and mouse embryonic
limb. In each species, we examined individual time points from
the bud stage through the onset of digit separation: embryonic
day 33 (E33) through E47 in human, E31–E36 in rhesus
and E10.5–E13.5 in mouse (Figure S1A available online). The
morphology of these human, rhesus, and mouse specimens
indicates they encompass comparable developmental time
frames across all three species. At early stages (E33 and E41
in human), we mapped H3K27ac in the entire limb bud. At later
stages (E44 and E47), we focused on the handplate and foot-
plate. We combined forelimb and hindlimb tissues in all experi-
ments and included two biological replicates at each time point
for human and mouse (Extended Experimental Procedures). We
identified thousands of H3K27ac-enriched regions at all stages
in all three species (Figures 1A and S1B; Table S1). H3K27ac
regions within 1 kb upstream of a transcription start site were
annotated as promoters, whereas intergenic or intronic regions
were annotated as putative enhancers. We identified a subset
of putative enhancers that are strongly marked in limb compared
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Figure 2. H3K27ac Signal Profiles in Human Embryonic Limb at Experimentally Validated Enhancers
The normalized H3K27ac signal (Extended Experimental Procedures) and corresponding enriched region (green), in human E41 limb bud at four sequences
demonstrated in a mouse transgenic enhancer assay to drive reproducible LacZ expression in E11.5 mouse limb (indicated by arrows). Images and enhancer
locations were obtained from the VISTA Enhancer Browser (http://enhancer.lbl.gov) (Visel et al., 2007). The location of each sequence tested in the enhancer
assay is shown as a black bar, accompanied by the corresponding genomic coordinates (UCSC hg19 assembly) and VISTA identifier. The level of sequence
conservation (phastCons scores) at each site in placental mammals is shown in blue.to other human cell types and are overrepresented near genes
with strong limb-specific expression or known functions in limb
development (Figures 1B, 1C, and S1C). Similar enrichments
were obtained in mouse (Figure S1D) (Shen et al., 2012). More-
over, 60% of human sequences known to act as limb enhancers
in mouse transgenic assays are marked by H3K27ac in the
human limb, demonstrating that H3K27ac enriches for tissue-
specific enhancer activity (Figures 1D and 2) (Visel et al., 2007).
Comparisons among individual human time points revealed
temporal patterns of enhancer activation (Figure S1E). En-
hancers active at early stages of human limb development are
associated with genes involved in pattern formation along the
anterior-posterior axis of the limb, whereas enhancers activated
later are enriched near genes contributing to the function andgrowth of differentiated tissues such as muscle (Figure S1E)
(Taher et al., 2011).
To evaluate at a molecular level whether the human, rhesus,
and mouse limb specimens we selected represent comparable
developmental time frames, we considered temporal changes
in the distribution of H3K27ac at the HOXD cluster in all three
species. As mouse limb development proceeds, genes located
at the 50 end of the cluster (e.g., HoxD13) are preferentially acti-
vated, whereas genes located at the 30 end become progres-
sively less transcribed (Spitz et al., 2003; Tarchini and Duboule,
2006). The deep evolutionary conservation of HOXD cluster
genes suggests their spatiotemporal activation patterns are
likely to be conserved across mammals. The spatial and tempo-
ral distribution of H3K27ac signal at the HOXD locus is highlyCell 154, 185–196, July 3, 2013 ª2013 Elsevier Inc. 187
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Figure 3. Cross-Species Comparisons of H3K27ac Marking in the Embryonic Limb
(A) Spearman correlation matrix of H3K27ac signal at orthologous sites in all three species generated by this study.
(B) Principal component analysis of H3K27ac signal at orthologous sites in all data sets. The proportion of variance explained by the first three components is
shown. See also Figure S3B.
(C) A schematic illustrating the cross-species H3K27ac signal comparison strategy used in this study. An idealized example of human lineage gain at E33 is
shown.
See also Figures S2 and S3A and Table S2.consistent in our human, mouse, and rhesus limb specimens:
H3K27ac marking shifts toward HOXD13 as limb development
progresses in each species (Figure S2). This provides further
evidence that we are comparing similar developmental windows
in our analysis.
The Extent of Human Lineage Gains in H3K27ac at
Promoters and Enhancers in the Limb
We first considered potential increases in promoter and
enhancer activity on the human lineage. To detect these events,
we focused on sites in the human genome that showed
reproducible enrichment of H3K27ac in two biological replicates
at each time point and exhibited a significant increase in
H3K27ac signal compared to the orthologous locations in rhesus
and mouse (Figures 3 and S3A). Comparing signal at ortholo-
gous regions mitigates false positives due to sequence copy
number changes among species, which include lineage-specific188 Cell 154, 185–196, July 3, 2013 ª2013 Elsevier Inc.paralogous elements and repeats that are difficult to study using
short read alignments (Alkan et al., 2011). In all comparisons, we
used the number of reads mapped to each orthologous site in
each native genome, normalized for sequencing depth and spe-
cies differences in orthologous element length. We did not
require that an H3K27ac-enriched region be called at the orthol-
ogous site in rhesus or mouse at any stage; theremay or may not
be an enriched region present in these species.
H3K27ac signals from orthologous regions were well corre-
lated between replicates in each species (Figure 3A). In addition,
essential regulators of limb development, including PITX1 and
TBX5 (Duboc and Logan, 2011), exhibit similar H3K27ac profiles
at promoters and putative enhancers across all three species,
consistent with their highly conserved functions and further rein-
forcing the overall quality of our data (Figure S4A). To gain an
initial global view of cross-species similarities and differences
in H3K27ac profiles we performed principal component analysis
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Figure 4. Identification of Promoters and Enhancers with Human
Lineage Gain of H3K27ac
(A) Number of orthologous promoters and enhancers marked by H3K27ac at
each time point. The percentage exhibiting stable marking or human lineage
gain of marking is indicated in each bar.
(B) Gene ontology and mouse phenotype enrichments for human gain
enhancers calculated using GREAT (McLean et al., 2010) (y axis = log10
binomial p value).
See also Figure S4 and Tables S2, S3, S4, S6, and S7.(PCA). In the PCA, H3K27ac data sets are separated according
to evolutionary distance: human and rhesus, although clearly
distinct, are more similar to each other than either is to mouse
(Figure 3B). PCA of human and mouse H3K27ac limb data with
published human andmouse embryonic stem cell and adipocyte
H3K27ac data separated each data set by tissue or cell type (Fig-
ure S3B) (Mikkelsen et al., 2010; Shen et al., 2012).
To identify potential human lineage gains, we required that
reproducibly marked H3K27ac sites at each time point in human
show a significant increase in H3K27ac signal compared to all 12
mouse and rhesus limb data sets in our study (Figure 3C;
Extended Experimental Procedures). We independently identi-fied gains at each human time point in light of the temporal
changes in H3K27ac activation we identified in human limb
development (Figure S1E). Moreover, given the uncertainty in
precisely matching developmental stages across species, we
chose to identify H3K27ac gains at each human time point rela-
tive to a broad range of developmental stages in rhesus and
mouse rather than attempting to compare specific stages. In
total, we identified 2,175 promoters and 2,915 enhancers with
a significant increase in H3K27ac on the human lineage at
one or more time points (Figure 4A; Tables S2 and S3). We
considered each time point-specific set of promoters and
enhancers with human gains independently in subsequent
analyses. The distribution of orthologous sequence length
changes in mouse and rhesus were similar for all human
H3K27ac regions and regions with human lineage gain of
marking, indicating that cross-species changes in sequence
length are not producing overestimates of human lineage
changes in H3K27ac (Figure S4B).
Human lineage gains at promoters (‘‘human gain promoters’’)
represent 2% (at E33) to 16% (at E47) of all orthologous
promoters in our analysis. Human lineage gains at putative
enhancers (‘‘human gain enhancers’’) occurred at 7% (at E33)
to 16% (at E47) of orthologous enhancers. These gains reflect
regulatory changes arising after divergence of the human and
rhesus lineages and likely include changes on the human lineage
that postdate the human-chimpanzee split. Genes associated
with promoters and enhancers exhibiting human gains of
H3K27ac were enriched for functions related to proliferation
and growth, bone morphogenesis, and connective tissue (Fig-
ures 4B and S4C). Human gain enhancers are also enriched
near genes with mouse limb phenotypes, suggesting some
human gain events influence genes with conserved limb func-
tions. We confirmed increases of H3K27ac at 21 of 28 regions
(75%) by ChIP-qPCR in human E44 limb versus both E11.5
and E13.5 in mouse (Figure S4D).
We also considered potential losses of promoter and
enhancer activity on the human lineage. We only identified 74
orthologous regions exhibiting loss of H3K27ac in human
compared to rhesus and mouse (Table S4). The asymmetry
between gains and losses we observed is consistent with a pre-
vious comparative study of DNase I hypersensitivity sites in
human, chimpanzee, and rhesus cultured cells and is likely due
to our study design (Shibata et al., 2012). Human gain of
H3K27ac may in principle occur at any site whether or not that
site exhibits H3K27ac marking in any other species or has a
conserved regulatory function. However, our study design only
allows us to identify human losses that entail reduction in
H3K27ac compared to rhesus and mouse. These sites are
more likely to include cis-regulatory functions conserved in
both species and thus under deep evolutionary constraint in
mammals.
Evolutionary Origins of Human Lineage Increases
in H3K27ac at Promoters and Enhancers
We next sought to determine the evolutionary origin of human
lineage gains in promoter and enhancer marking. We first
compared sequence conservation levels of three subsets of
enhancers active in human limb: all enhancers with orthologousCell 154, 185–196, July 3, 2013 ª2013 Elsevier Inc. 189
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Figure 5. Conservation and Putative Ances-
tral Activities of Promoters and Enhancers
with Human Lineage Increases in H3K27ac
(A) Mean per-element conservation and hetero-
zygosity values (1000 Genomes Project Con-
sortium et al., 2012) for all orthologous human limb
enhancers (blue), stably marked enhancers
(green), human gain enhancers (red), and back-
ground intergenic or intronic regions (gray).
p values are shown for comparisons discussed
in the text.
(B) Distribution of age estimates for all orthologous,
stably marked, and human gain enhancers at hu-
man E44, mapped onto the known phylogeny of
vertebrate genomes used in the analysis. We esti-
mated the age of each enhancer by identifying the
most distant vertebrate lineage with an ortholo-
gous sequence (Extended Experimental Pro-
cedures). Estimated ages (in millions of years) for
internal nodes in the phylogeny are shown. In the
box plots, the right, middle and left bars of the
boxes represent the 25th, 50th, and 75th percentiles
of the data, respectively. Whiskers extend from the
box to the most extreme data point that is <1.5
times the interquartile range. Human gain en-
hancers show a significantly more recent origin
compared to all orthologous and stably marked
regions (***, Wilcoxon rank-sum p < 0.0001). See
also Figure S5A.
(C and D) Inferred human gain mechanisms based on human E44 H3K27ac marking at the orthologous rhesus and mouse position in a total of
19 tissues and cell lines, for promoters (C) and enhancers (D).
See also Figures S5B and S6 and Tables S3 and S6.sequences in rhesus andmouse, enhancers with similar levels of
H3K27ac across all three species (‘‘stably marked’’ enhancers),
and human gain enhancers at each time point. Many known
developmental enhancers are deeply conserved in vertebrates,
and previous efforts to identify human-specific enhancer func-
tions have consequently targeted highly conserved noncoding
sequences that exhibit increased rates of human-specific
sequence change (McLean et al., 2011; Pollard et al., 2006;
Prabhakar et al., 2006). However, the majority of human lineage
increases in H3K27ac we detected do not involve extremely
conserved elements. Although human gain enhancers are signif-
icantly more conserved than background sequence, they are
less conserved than stably marked enhancers (Figure 5A).
Human gain enhancers and stably marked enhancers do
not show a significant difference in overall genetic diversity,
based on single-nucleotide variation data obtained in the 1000
Genomes Project (1000 Genomes Project Consortium, 2012)
(Figure 5A; Extended Experimental Procedures). This suggests
that human gain enhancers are potentially under similar func-
tional constraint in modern human populations as stably marked
enhancers. However, we note that recently identified ascertain-
ment biases and false positives in 1000 Genomes variant data
may confound this analysis (Ward and Kellis, 2012, 2013; Green
and Ewing, 2013).
The median age of E44 human gain enhancers dates to the
common ancestor of opossum and placental mammals,
although a subset of enhancers is more ancient (Figure 5B). In
contrast, both stably marked and all orthologous enhancer
sequences in E44 human limb are significantly older: a greater190 Cell 154, 185–196, July 3, 2013 ª2013 Elsevier Inc.fraction of elements in each class are present in nonmammal
vertebrate genomes. Enhancers at other time points showed
similar trends, validating the robustness of our observations
(Figure S5A). Human gain enhancers are also significantly less
conserved than stably marked enhancers both in primate-rodent
comparisons and across placental mammals, suggesting they
have a more recent evolutionary history and are less conserved
overall (Figure S5A). The median age of human gain promoter
sequences identified at each time point predates the origin of
mammals (Figure S5A). Although human gain promoters at E44
and E47 show a significantly more recent evolutionary origin
than stably marked promoters, human gain promoters at E33
and E41 are not significantly younger. Despite their age,
human gain promoters at each time point are significantly less
conserved across placental mammals than stably marked
promoters (Figure S5A).
To evaluate the potential ancestral regulatory activity of
regions with human lineage gains, we examined H3K27ac
enrichment at orthologs of human gain promoters and en-
hancers in rhesus and mouse limb, as well as in 18 nonlimb
mouse tissues (Shen et al., 2012). Although the quantitative
approach we used to identify human gains does not require
that the orthologous site in rhesus or mouse show significant
H3K27ac enrichment, there may be a significant peak present,
indicating an ancestral regulatory function. Human lineage gains
may thus have arisen by modification of an existing regulatory
element in the limb, co-option of a regulatory element active in
another tissue, or de novo. At E44, we find that 91% of human
gain promoters show significant H3K27ac enrichment in the
rhesus or mouse limb, indicating human gain through modifica-
tion (Figure 5C). A smaller fraction, 6%, are not marked in rhesus
ormouse limb, but aremarked in at least one othermouse tissue,
suggesting theymay have been co-opted into human limb devel-
opment. Finally, 3% of human gain promoters show no marking
in any mouse or rhesus tissue we examined, suggesting they
may involve de novo gain of activity. Similar trends were
observed for the remaining human limb time points (Figure S5B).
A greater fraction of human gain enhancers showed evidence of
potential co-option or de novo gain compared to promoters.
Modifications of ancestral limb regulatory activity may have
occurred at 62% of E44 human gain enhancers, 18% are poten-
tial co-option events, and 20% are potential de novo gains (Fig-
ure 5D; Table S3). Similar trends were observed for other human
limb time points, although at earlier stages a larger proportion of
enhancers may arise from de novo gains (Figure S5B).
The genetic basis of the human lineage gains we identified
remains to be determined. Sixteen conserved noncoding
sequences exhibiting accelerated rates of sequence change in
human evolution identified in previous studies show gain of
H3K27ac on the human lineage (Lindblad-Toh et al., 2011; Prab-
hakar et al., 2006) (Table S5). However, our analysis suggests
that, in general, promoters or enhancers showing human lineage
gains do not exhibit a human-specific increased substitution rate
relative to other primate species. Rates of human-specific, chim-
panzee-specific, ape-specific, and rhesus-specific change were
all elevated in these sequences, potentially due to their lower
level of sequence conservation (Figure S6; Extended Experi-
mental Procedures). Human lineage gain sites also did not
show human-lineage enrichment for particular transcription
factormotifs or repetitive elements (Table S6). These results sug-
gest human lineage H3K27ac gains may have heterogeneous
genetic origins and highlight the difficulty of identifying regulatory
gains using purely sequence-based comparative metrics.
Lineage-specific sequence gains and changes in copy num-
ber could also contribute to human lineage gains of regulatory
function. Approximately 8% and 22% of H3K27ac-enriched
sites identified at each time point in human limb do not have a
clearly identifiable ortholog in rhesus or mouse, respectively
(Table S1). We have excluded these sequences from our
analysis. Based on multiple sequence alignments, we could
only identify 14 (0.06%) and 123 (0.5%) putative limb en-
hancers with sequences specific to human or ape respectively
(Table S3). However, our analysis may underestimate the contri-
bution of lineage-specific sequence change, as many human
lineage gains of sequence are driven by recent duplication and
accurately mapping 75 bp reads to such sequences is chal-
lenging (Alkan et al., 2011).
Human Lineage Increases in H3K27ac Reveal Human
Lineage Promoter and Enhancer Activities
Our results suggest human gain of H3K27ac reveals regulatory
activities arising on the human lineage that may impact gene
expression during development. Human lineage increases
at promoters in E44 limb were significantly correlated with
increased gene expression in human relative to the orthologous
genes in mouse (Figure 6A; Table S7). Nearly 30% (142 of 502) of
the orthologous genes associated with a human gain promoterexhibit a 4-fold or greater increase in gene expression in the
human limb compared to mouse. This represents a significant
enrichment compared to the fraction of 7,484 orthologous genes
that show a 4-fold or greater expression increase in human (943
of 7,484, Fisher’s exact test p value = 1.23 3 1022). Human
lineage gain enhancers were also significantly enriched near
genes with R4-fold increases in expression level in human
limb compared to mouse (Figures 6B and S7A).
Genes associated with human gains of H3K27ac at promoters
and enhancers and that exhibit increased expression in human
limb, are candidates for producing human-specific limb pheno-
types. One such gene, ARHGAP6, shows increased marking in
human at both of its known promoters as well as a nearby
enhancer and is highly expressed in human limb compared to
mouse (Figures 6C and S7B). The mouse ortholog resides in
the Xpl locus, which includes an unknown dominant regulatory
mutation that gives rise to polydactyly and elongation and thick-
ening of digit one in hindlimb (Cormier et al., 2001; Masuya et al.,
1997) (Figure S7C).
An enhancer with human-specific activity in the limb,
HACNS1, also shows significantly increased H3K27ac marking
on the human lineage (Figure 7A) (Prabhakar et al., 2008).
Human-specific sequence changes in this element confer
strong limb expression in a mouse transgenic enhancer assay
compared to the orthologous chimpanzee and rhesus elements
(Figure 7B). H3K27ac marking at HACNS1 is strongest in E33
human limb, consistent with its robust limb enhancer activity
at mouse E11.5. These results suggest that human lineage
increases in H3K27ac marking may help identify enhancers
with potential human-specific developmental functions and
provide a means to prioritize candidates for downstream exper-
imental analyses.
DISCUSSION
The systematic identification of genetic and molecular changes
that distinguish humans from other species is essential for un-
derstanding the evolution of uniquely human traits. In this study,
we globally mapped promoters and enhancers active during crit-
ical stages of limb development in human, rhesus, and mouse,
from patterning of the limb bud through emergence and separa-
tion of the digits. Our results provide a direct, genome-wide view
of both conserved and human lineage-specific cis-regulatory
activities in the embryonic limb. Using quantitative phylogenetic
analysis of H3K27ac marking, we identified several thousand
promoters and enhancers that show increased activity on the
human lineage. Not all of the human lineage gains are likely to
affect gene expression, or be relevant to human limb pheno-
types. However, our results provide several starting points to
identify candidates for downstream studies and enable func-
tional studies of regulatory change in human limb evolution.
First, we identified 302 genes that show 4-fold or greater
expression in human limb relative to mouse and that are associ-
atedwith human promoter or enhancer gains (Figures 6A and 6B;
Table S7). These results support that H3K27ac gains at pro-
moters and enhancers in human do contribute to increased
gene expression. Enhancers showing lineage-specific gain of
activity in human and that are associated with genes showingCell 154, 185–196, July 3, 2013 ª2013 Elsevier Inc. 191
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Figure 6. Human Lineage Increases in H3K27ac Correlate with Human Lineage Regulatory Activities
(A) Comparison of differential promoter H3K27ac marking and differential gene expression in human E44 and mouse E11.5 limb for 7,484 orthologous genes.
Spearman rank correlation coefficient and p value, r and p respectively, indicate a significant positive correlation between H3K27ac level and gene expression.
Grey dots represent 7,484 one-to-one orthologous genes between human and mouse. Black circles indicate 502 human genes associated with human gain
promoters. Red circles indicate 142 human genes associated with gain promoters that also show aR4-fold change of gene expression in human compared to
mouse. Genes with potential roles in human limb phenotypes are named and labeled in black. See also Table S7.
(B) Fraction of human gain or the same number of randomly sampled stably marked regions assigned to a gene with the indicated level of increased expression in
human E44 limb compared to mouse E11.5 limb (see also Figure S7A). Error bars represent 99.9% quantile values from 1,000 sampling iterations (Extended
Experimental Procedures).
(C) Limb H3K27ac signal from the indicated human, rhesus, and mouse time points at the promoter (left) and a potential enhancer (right) of the ARGHAP6 gene.
Horizontal bars indicate regions of H3K27ac enrichment. Coordinates for human, rhesus, and mouse are for hg19, rheMac2, and mm9 genomes respectively.
Vertical green bars indicate total signal in human region and relative signal in orthologous regions from rhesus and mouse; p values indicating significant human
lineage increasedmarking are shown. Vertical black and gray bars indicate relative ARGHAP6 expression determined by human E44 andmouse E11.5 RNA-seq.
See also Figure S7B and Table S7.increased expression, are candidates for initial in vivo analysis in
the mouse using comparative transgenic enhancer assays (Fig-
ure 7). Characterizing morphological changes in the limb or other
structures arising due to lineage-specific enhancer functions
identified by this approach will then require humanized mouse
models, in which enhancers showing human-specific activity192 Cell 154, 185–196, July 3, 2013 ª2013 Elsevier Inc.are introduced by homologous recombination into the mouse
genome. These studies would also provide insight into potential
systemic effects of human lineage regulatory changes in limb
development, including increases or decreases of downstream
gene expression due to direct (e.g., enhancers acting to up-
regulate promoters) or indirect mechanisms (e.g., increased
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Figure 7. Human Lineage Increases in H3K27ac Identify an Enhancer with Human-Specific Regulatory Function In Vivo
(A) Normalized H3K27ac signal in human E33 limb at a conserved noncoding sequence exhibiting human-specific accelerated evolution (HACNS1) and at the
orthologous positions in rhesus and mouse. The horizontal green bar indicates the H3K27ac-enriched region called in human. The H3K27ac signals at the
orthologous positions in rhesus and mouse are also shown for the indicated time points. The location of HACNS1 is indicated in black; whiskers indicate
the sequence shown to have human-specific enhancer activity in amouse transgenic assay. p values indicate significantly increasedmarking in human compared
to rhesus and mouse. See also Tables S2 and S5.
(B) Activity of HACNS1 and its rhesus ortholog, indicated by LacZ reporter activity in mouse E11.5 transgenic embryos.expression of a repressive factor that downregulates multiple
genes). We provide a list of all 2,304 known human and mouse
orthologous genes associated with human gain promoters or
enhancers in Table S7.
Second, our results suggest that modification of existing limb
regulatory programs may contribute to unique human limb
morphology. The human hand is distinguished from that of other
primates by the increased relative length of the first digit and
reduced curvature of the digits, which have served to increase
its dexterity (Marzke and Marzke, 2000). The human foot has
evolved a rigid structure that allows it to act as a lever during
walking, and the first digit is no longer opposable to the other
digits (Aiello and Dean, 2002). At a genome-wide level, we
show that human lineage gains in H3K27ac marking are associ-
ated with genes important for limb development (Figures 4B and
6). These analyses also revealed specific genes that show hu-
man lineage regulatory changes in limb and have known limb
phenotypes in mouse. We identified human gains of promoter
activation and increased gene expression of EGR1 and CILP,
which are involved in tendon (Lejard et al., 2011) and cartilage
formation (Lorenzo et al., 1998), respectively. We also detected
multiple human regulatory gains and increased gene expression
at ARHGAP6. In the mouse, this gene resides in a locus that
includes a putative cis-regulatorymutation resulting in a hindlimb
phenotype that closely mirrors evolutionary changes in the
human foot, such as thickening of the first digit (Figure S7C)
(Masuya et al., 1997, Bramble and Lieberman, 2004). We also
identified an enhancer gain associated with a human lineage in-
crease in expression for EFEMP1. This gene has been implicated
in regulating chondrocyte differentiation (Wakabayashi et al.,
2010) and has been associated with variation in human height
(Weedon et al., 2008; Zhao et al., 2010). These genes and theirassociated regulatory changes are high-priority candidates for
experimental characterization.
Third, our results enable direct interpretation of human accel-
erated regions (HARs or HACNSs) identified by previous studies
and allow their prioritization for downstream analysis (Pollard
et al., 2006; Prabhakar et al., 2006). These elements were
defined by purely computational means and have generally
resisted large-scale efforts to identify their functions due to a
lack of associated, relevant experimental data. We show that
human lineage increases in H3K27ac may be used to identify
human accelerated sequences with human-specific regulatory
activity (Figure 7). We have identified 16 human accelerated
regions that show significant increases in H3K27ac on the
human lineage. The results shown in Figure 7 provide a proof
of principle for using mouse transgenic assays to characterize
potential human-specific regulatory functions in this larger set
of elements. As discussed above, characterizing the phenotypic
effects of regulatory changes in human accelerated regions will
require humanized mouse models.
In addition to their utility for identifying candidates for experi-
mental study, our results provide general insights into the origin
and abundance of human lineage gains of developmental
enhancer activity. We estimate that 2%–16% of enhancers
show evidence of human lineage gain of H3K27ac marking
relative to rhesus and mouse, depending on the time point
examined. It is not feasible to obtain embryonic tissues from
chimpanzee, so we could not directly determine the rate of
human enhancer gains since the human-chimpanzee split. How-
ever, because these events are a subset of the human-rhesus
differences we identified, the rate of human lineage gain of activ-
ity at enhancers relative to chimpanzee is likely to be less than
the estimates we obtained from human-rhesus comparisons.Cell 154, 185–196, July 3, 2013 ª2013 Elsevier Inc. 193
We note that our estimates are based on a small number of
replicates in each species, due to the difficulty in obtaining
human and rhesus embryonic tissues. A subset of the human
gains we identified are likely to be false positives due to technical
issues arising from our limited sample size, or may be polymor-
phic in human populations. Moreover, we may lack power to
reliably detect small increases in H3K27ac marking due to our
sample size, so wemay be underestimating weak human lineage
gains. Additional biological replicates in human and rhesus
would refine the estimates we provide here and better distin-
guish between gains that are fixed on the human lineage and
epigenetic variation within humans. We also note that our human
gain estimates are specific to promoters and enhancers that
are marked by H3K27ac. Comparative analysis of other histone
modifications, or of other factors that mark regulatory se-
quences, may reveal a greater or lesser number of human gains.
Many of the human lineage gains we identified appear to
involve modification of ancestral enhancer activities, based on
patterns of H3K27ac marking at their rhesus and mouse or-
thologs. Our analysis also revealed a subset of human gain
enhancers that may involve de novo genesis of regulatory func-
tion. However, we have not exhaustively characterized H3K27ac
in all rhesus andmouse tissues, sowemay be overestimating the
frequency of de novo gains. In addition, human gain enhancers
are less conserved and have a more recent evolutionary origin
than the average enhancer active in the human limb, suggesting
that regulatory changes contributing to human limb morphology
generally involve modification of mammal-specific enhancers,
rather than enhancers deeply conserved in vertebrates. Com-
bined, these results point to a conservative process of regulatory
change in the evolution of the human limb.
The human lineage gains in enhancer activity we identified are
likely to have diverse genetic causes. We found no evidence of
human-specific enrichment for any known transcription factor
motif in these elements, and they exhibited no significant
human-specific or ape-specific sequence acceleration com-
pared to chimpanzee-specific or rhesus-specific substitution
rates. This suggests many human lineage gains may be due to
a small number of substitutions with large effects in each
element and introduce or remove binding sites for a broad set
of transcription factors overall. Novel regulatory sequences
may also be generated by exaptation of transposable elements
(Feschotte, 2008). However, repeat exaptation at orthologous
sites does not appear to substantially contribute to the genera-
tion of human lineage-specific enhancer activities in the limb
and neither do lineage-specific sequences (Tables S3 and S6).
Nevertheless, we may be underestimating the abundance of
human lineage regulatory changes at lineage-specific and paral-
ogous sequences due to the inherent computational challenges
in mapping short reads to recently duplicated sequences. We
were unable to clearly identify a single orthologous sequence
in rhesus for 8%of enriched H3K27ac sites in human limb. These
sequences may encode human-specific regulatory functions
relevant to human limb evolution, but this cannot be determined
using the strategy we employ here.
We observed a higher degree of regulatory conservation
among human, rhesus, and mouse limb compared to several
previous studies of transcription factor binding in human and194 Cell 154, 185–196, July 3, 2013 ª2013 Elsevier Inc.mouse embryonic stem cells and adult liver and histone modifi-
cations in human and mouse adipocytes (Figure 4A; Table S1)
(Kunarso et al., 2010; Mikkelsen et al., 2010; Schmidt et al.,
2010). This may be due to the conservative approach we used
to identify human lineage quantitative changes in H3K27ac. It
may also reflect the increased specificity of H3K27ac compared
to binding of single transcription factors for detecting active reg-
ulatory elements. Deposition of H3K27ac is likely a terminal step
in enhancer activation (Creyghton et al., 2010; Rada-Iglesias
et al., 2011), whereas many transcription factor binding events
appear to be incidental to regulatory function and thus may
be poorly constrained (Go¨ke et al., 2011; Junion et al., 2012).
Tissue-specific variation in the frequency of species-specific
regulatory change may also be a factor, arising due to different
constraints on regulatory functions among developing and adult
tissues (Brawand et al., 2011). Ensuring homology is another
major consideration: the limb is unambiguously homologous
(Figure S1A), whereas cell culture models may exhibit very
different biological characteristics that confound cross-species
analysis, even if they are ostensibly derived from homologous
tissues. Analysis of regulatory divergence in multiple homolo-
gous embryonic tissues, such as the brain and the heart, using
the strategy we have implemented here would yield insight
into these questions and enable comprehensive experimental
studies of uniquely human biology.
EXPERIMENTAL PROCEDURES
Tissue Collection, ChIP-Seq, and RNA-Seq
Human embryonic limb tissue was collected, staged, and provided by the
Joint MRC/Wellcome Trust Human Developmental Biology Resource. Tissues
were flash frozen upon collection and stored at 80C. Human limbs were
staged using the Carnegie staging system (O’Rahilly et al., 1987) and only
tissues matching these criteria were used in our experiments. The use of
human embryonic tissue in this study was reviewed and approved by the
Yale Human Investigation Committee. For each time point replicate, a single
forelimb and single hindlimb autopod from the same embryo were combined,
homogenized, and crosslinked as described for mouse tissue (Cotney et al.,
2012). Fetal rhesus limb tissue from gestational days 31 to 36 was harvested
according to approved Yale IACUC protocols (Dominguez et al., 2012). Single
forelimb and single hindlimb rhesus autopods were combined as for human
experiments. Mouse embryos were harvested in accordance with approved
Yale IACUC protocols. Only autopod tissue from forelimb and hindlimb were
used for E12.5 and E13.5 experiments. Chromatin extraction, shearing, immu-
noprecipitation, and sequencing were performed as previously described
(Cotney et al., 2012). For RNA-Seq experiments, digit one was separated
from remaining digits of E44 forelimb or hindlimb autopod tissue and placed
directly in Qiazol. RNA was extracted and sequenced as previously described
(Cotney et al., 2012). Data from these experiments was combined computa-
tionally to generate composite limb expression values (Extended Experimental
Procedures).
Validation of Human-Specific H3K27ac Regions
Human gain H3K27ac regions at E44 were chosen for testing that had an
average reads per kilobase per million (RPKM) R1 and when lifted to the
mouse genome changed <10% in overall length to enable meaningful compar-
ison by QPCR. Human DNA sequence (300 bp) surrounding the peak of signal
within each enriched region were selected and QPCR amplicons were
designed using BatchPrimer3 (You et al., 2008). These 300 bp regions were
lifted to the mouse genome and QPCR amplicons were designed as above
(Table S3). Two independent human E44 limb samples were subjected to
ChIP as above. Resulting enriched genomic DNA was used as template for
QPCR. Human gain was determined by normalizing human E44 H3K27ac
ChIP Ct values versus input Ct values in a fashion similar to DDCt values typi-
cally utilized in detecting gene expression differences via RT-QPCR. p values
were calculated by two-way ANOVA with Prism v5 (GraphPad).
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